Here are relevant reports on : blood-collection-needles-market
-
Cell Therapy Technologies Market by Product (Media, Sera, Reagents, Vessels, Equipment), Process (Expansion, Isolation, Characterization, Collection, Preservation, Distribution, QC), Type (T-cells, Stem Cells), Application (Cancer) - Global Forecast to 2030
The global cell therapy technologies market, valued at US$4.05 billion in 2024, stood at US$4.41 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$7.91 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Rolling Stock Management Market by Management (Rail, Infrastructure), Rail (Remote Diagnostic, Wayside, Train, Asset, Cab Advisory), Infrastructure (Control Room, Station, Automatic Fare Collection), Maintenance Service & Region - Global Forecast to 2025
The global rolling stock management market is projected to grow from USD 42.8 billion in 2019 to reach USD 58.4 billion by 2025, at a CAGR of 5.32%. The rising concerns over safety, security, inspection, maintenance, and in the transport business has led to the growth of the rolling stock management market. It not only includes the fact of reducing long term cost but also mitigating the traditional methods of maintenance. Transport can be through the medium of air, road, or train but its efficiency and effect on the environment. The emerging nations support railways as a well-suited means of mass transport for passengers and freight.Bombardier (Canada), Alstom (France), General Electric (US), and Siemens (Germany).
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application (Personalized Storage, Clinical (Autoimmune, Hematopoietic Disorders), Research) - Global Forecasts to 2023
The global stem cell banking market is projected to reach USD 9.30 Billion by 2023, at a CAGR of 8.2%. Major players in the global stem cell banking market include Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Intelligent Apps Market by Type (Consumer Apps, Enterprise Apps), Provider (Infrastructure, Data Collection & Preparation), Store Type (Google Play, Apple App Store), Deployment Mode, Service, Vertical, and Region - Global Forecast to 2023
MarketsandMarkets expects the global intelligent apps market to grow from USD 11.34 billion in 2018 to USD 46.98 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 32.9% during the forecast period. Major driving factors for the market include increasing use of smartphones driving the demand for greater business mobility, rising consumer expectations for rich contextual and personalized experience, and growing focus on effective and real-time mobile advertising. Major vendors in the global Intelligent apps market include IBM (US), Google (US), AWS (US), Microsoft (US), Salesforce (US), Oracle(US), Apple (US), Baidu (China), SAP SE (Germany), ServiceNow (US), Facebook (US), Intel (US), HPE (US), Avaamo (US), H2O.ai (US), BigML (US), Sentient Technologies (US), Clarifai (US), CloudMinds (US), Ayasdi (US), Narrative Science (US), AIBrain (US), Dation (US), Arkenea Technologies (US), iCarbonX (US), and Fuzzy.ai (US).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030
The global diabetes care devices market, valued at US$30.8 billion in 2024, stood at US$34.3 billion in 2025 and is projected to advance at a resilient CAGR of 12.3% from 2025 to 2030, culminating in a forecasted valuation of US$61.2 billion by the end of the period. The global increase in diabetes cases, driven by lifestyle changes, dietary habits, and rising obesity rates, is significantly boosting the demand for diabetes care devices.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Western Blot), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Laboratories) - Global Forecast to 2030
The global immunoassay market, valued at US$34.4 billion in 2024, stood at US$35.5 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$47.7 billion by the end of the period. This growth is primarily driven by the increasing prevalence of chronic and infectious diseases worldwide, which has boosted the demand for early and accurate diagnostic solutions.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030
The global in vitro diagnostics market, valued at USD 101.05 Billion in 2024, stood at USD 109.06 Billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of USD 157.63 Billion by the end of the period. Market growth is primarily fueled by the rising prevalence of chronic and infectious diseases, increasing demand for rapid and accurate diagnostic solutions, and the growing shift toward personalized medicine.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Apheresis Market by Product (Device, Disposable), Procedure [Donor, Therapeutic (Neurological, Blood)], Application (Plasmapheresis, Plateletpheresis), Technology (Centrifugation, Membrane Separation), End User (Clinic) - Global Forecast to 2031
The global apheresis market is projected to reach USD 4.41 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018
The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.
- Published: August 2013
- Price: $ 4950
- TOC Available:
-
European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017
The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).
- Published: July 2013
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
